SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is gaining traction, with community members highlighting its availability on Phantom Wallet and relative stability amidst market fluctuations. The crypto is being touted as a potential "moon" candidate, with buyers sharing enthusiasm. Conversations are centered on its performance within the Solana ecosystem.

Moo Deng

MOODENG is trending as traders discuss recent price volatility and potential for a breakout. Community members are debating entry points, with some pointing to technical analysis patterns, while others express skepticism, citing its meme coin status and past performance. The coin's listing on Robinhood and upcoming birthday are also being mentioned as potential catalysts.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

GBTC is trending as Bitcoin flirts with all-time highs, driving discussion about potential breakouts and future price targets. Community members are closely watching technical indicators and whale activity, anticipating a continued uptrend. Broader market factors, like potential shifts from gold to Bitcoin and the impact of government policies, are also being considered.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending following FDA approval of their leukemia drug, Revuforj, though a boxed warning regarding potentially fatal side effects tempers initial enthusiasm. The community is debating the impact of the safety label, comparing it to competitor Kura Oncology's profile, and weighing whether the market is overreacting given the drug's efficacy and the unmet need it addresses. Some believe the dip is a buying opportunity, while others worry about potential risks and side effects.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as community members discuss its potential as a Bitcoin-native meme coin, emphasizing its fair launch and strong community. Some see it as a compelling opportunity within the crypto space, drawing comparisons to other popular meme coins and highlighting its unique position on the Bitcoin network. Community members are actively sharing insights and expressing bullish sentiment, with some anticipating significant growth and exchange listings.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid discussions about a potential recall of specific lots and the impact on revenue, with community members analyzing the company's response and comparing it to similar situations with competitors. Some traders are interpreting recent stock sales by the CEO, alongside an FDA safety notice, while others suggest potential manufacturing issues. Despite concerns, many community members express confidence in the company's long-term growth and potential for a buyback.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending due to growing community engagement and real-world applications, with discussions focusing on its expanding ecosystem and the potential for significant growth. Community members highlight KENDU's unique approach as a permissionless brand, its active IRL presence, and the increasing number of holders. The recent release of a new website is also generating excitement, with many expressing confidence in KENDU's long-term potential.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the stock price continues to drop post FDA approval, leading to discussions around management, dilution, and future prospects. The community is debating whether the current price represents a buying opportunity or reflects deeper issues with the company's leadership and commercialization strategy. Some traders are noting potential short squeeze setups due to high short interest.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya is trending as investors discuss upcoming earnings and the company's potential for growth in the consumer credit sector, with some highlighting the AI-driven model as a key differentiator against competitors. Community members are debating the impact of recent bankruptcies of subprime lenders and analyzing insider trading activity, while also assessing the stock's valuation relative to peers like Upstart. Discussions also include speculation around potential deregulation and its impact.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

RIGL is trending due to increasing optimism surrounding its upcoming earnings and potential undervaluation, as highlighted by a low P/E ratio. The community is actively discussing the high short interest and potential for a short squeeze, with some speculating about a possible buyout. Positive analyst ratings and strong sales growth for key products like Tavalisse are also fueling investor interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EaseMyTrip Advances EaseMyTrip 2.0 Commitment with Four Strategic Acquisitions to Strengthen its Integrated Travel Ecosystem

EaseMyTrip (Easy Trip Planners Limited), one of India's leading online travel-tech platforms, today, after the board meeting, announced the approval of strategic acquisitions of four companies as part of its EaseMyTrip 2.0 commitment to build an integrated and diversified travel ecosystem by strategic investments through primary investments totaling 49 per cent.

In an ask-me-anything (AMA) session hosted on Stocktwits on Tuesday, SEBI-registered analyst Palak Jain shared her outlook on ten stocks, highlighting bullish breakouts, sideways consolidations, and key risk levels.&nbsp;From Kaynes Technology’s ascending triangle to Kotak Mahindra Bank’s long-term consolidation and Bajaj Auto’s decisive resistance zone, her insights offer traders a mix of breakout opportunities and cautionary signals.Let’s take a look at&nbsp;<a href="https://stocktwits.com/Financewithpalak">Palak Jain’s</a> recommendations:&nbsp;Kaynes Technology<a href="https://stocktwits.com/symbol/KAYNES.NSE">Kaynes</a> is showing an ascending triangle pattern with strong volume, suggesting bullish momentum. A breakout above ₹7,100 could trigger a rally, supported by positive volume and technical setup. Keeping a stop-loss just below the trendline is advisable for risk management<a href="https://stocktwits.com/symbol/NIFTY50.NSE">&nbsp;</a>Kotak Mahindra Bank&nbsp;<a href="https://stocktwits.com/symbol/KOTAKBANK.NSE">Kotak Bank</a> is in a multi-year consolidation phase, as shown by its sideways movement since 2019. Over a 1-year timeframe, a strong breakout above the highlighted resistance zone could trigger a new uptrend, but a lack of volume spike suggests patience is needed before a decisive move. Long-term investors should monitor for sustained highs; accumulation near support remains prudent.<stembedurl>https://stocktwits.com/Financewithpalak/message/627193358</stembedurl>Bajaj AutoJain flagged significant resistance at ₹9,072 for&nbsp;<a href="https://stocktwits.com/symbol/BAJAJ.AUTO.NSE">Bajaj Auto</a>. Stock has momentum; a decisive breakout above resistance could trigger a strong uptrend. Wait for breakout confirmation with above-average volume before initiating new positions. If resistance holds, expect a possible short-term reversal or consolidation. She added that it was essential to set a strict stop-loss just below the resistance for risk control. Higher volume on breakout adds conviction for sustained upside; otherwise, fake-out risk remains, Jain cautioned.Bombay Stock Exchange (BSE)<a href="https://stocktwits.com/symbol/BSE.NSE">BSE</a> is currently trading with a neutral trend and is expected to reach the 1-year average price target of ₹2,536–₹2,541, with highs of ₹3,200–₹3,360 and lows near ₹1,807–₹1,683. Whether BSE hits ₹2,400 or dips depends on broader market sentiment; right now, momentum is muted, and a sideways phase may continue until a strong trigger emerges.Angel One&nbsp;For&nbsp;<a href="https://stocktwits.com/symbol/ANGELONE.NSE">Angel One</a>, Jain pegged key support at ₹2,188, a level where price rebounded, indicating buyer interest. The stock trades in a falling channel; the trend remains weak unless it breaks out above the upper line, if price holds above support and breaks the channel with substantial volume, a trend reversal is possible. If ₹2,188 breaks, expect further downside; stay cautious for fresh positions. She recommended watching the next few sessions for a direction.HCL Technologies&nbsp;<a href="https://stocktwits.com/symbol/HCLTECH.NSE">HCL Tech</a> is trading in a rising channel, reflecting a strong long-term uptrend. Formation of higher highs and higher lows suggests continued bullish momentum. Lower channel boundary near ₹1,350 acts as significant support, and its recent bounce signals buyer strength. If price sustains above support, potential exists for a move towards upper channel resistance (~₹2,200).Garden Reach Shipbuilders (GRSE)<a href="https://stocktwits.com/symbol/GRSE.NSE">GRSE</a> has shown a cup and handle breakout pattern, which is bullish for long-term upside. A breakout above ₹2,750 confirms the formation of a cup and handle structure. Key support is seen at ₹2,190, and price staying above this keeps bullish bias intact. Continued strength could push price toward prior highs if breakout holds.Mangalore Refinery &amp; Petrochemicals (MRPL)<a href="https://stocktwits.com/symbol/MRPL.NSE">MRPL</a> stock is moving sideways, stuck in a tight range between support and resistance with no clear trend. The price has not broken out, so it’s best to wait for a move above the box for a strong rally or below for a fall; right now, momentum is weak and direction is uncertain.Easy Trip PlannersFor&nbsp;<a href="https://stocktwits.com/symbol/EASEMYTRIP.NSE">EaseMyTrip</a>, Jain identified support between ₹8.08 and ₹8.27, with resistance at ₹8.46 and ₹8.65. Traders can consider entering near the support level, with a stop-loss slightly below ₹8.08. And they can book profits near resistance levels, above ₹8.46–₹8.65.Trident&nbsp;For&nbsp;<a href="https://stocktwits.com/symbol/TRIDENT.NSE">Trident</a>, she sees support between ₹26.23 and ₹27.51, with resistance at ₹28.95 to ₹30.47. Jain advised traders to enter closer to support levels, with a stop-loss just below ₹26.23, with targets at resistance levels of ₹28.95–₹30.47 unless a breakout occurs.<stembedurl>https://stocktwits.com/Financewithpalak/message/627192666</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a stock chart | Image source: Maria Korneeva on Getty Images

Stocktwits AMA: SEBI Analyst Palak Jain Highlights Breakout Zones And Risk Levels For Ten Stocks

The analyst identified bullish structures in Kaynes and GRSE, cautioned on Angel One and MRPL, and shared critical resistance levels for Bajaj Auto.

Equity

The analyst identified bullish structures in Kaynes and GRSE, cautioned on Angel One and MRPL, and shared critical resistance levels for Bajaj Auto.


EaseMyTrip, Korea Tourism Organisation join hands to woo Indian tourists to travel to South Korea

The partnership seeks to drive Indian tourist arrivals to Korea by leveraging EaseMyTrip's digital reach, industry expertise, and extensive customer base, Easy Trip Planners, which operates under the brand EaseMyTrip, said in a regulatory filing.

Easemytrip’S Q3 Net Profit Tanks 26.3 Pc To Rs 33.6 Crore, Revenue Drops

(MENAFN - IANS) Mumbai, Feb 15 (IANS) Online travel service provider Easy Trip Planners Limited, which operates EaseMyTrip, reported a 26.3 per cent year-on-year (YoY) drop in net profit for the ...

Indian OTA EaseMyTrip partners with Sabah Tourism to attract Indian travelers

The shares of Easy Trip Planners Limited were trading at 13.04 up by 0.12 or 0.93 per cent on the NSE

Stock Radar: Aurobindo, Adani Ports, RVNL, NTPC, Torrent Pharma, Divis Labs, Glenmark in focus on Monday

More than 300 companies will release their quarterly earnings on May 27 including Life Insurance Corporation of India, Astrazeneca Pharma, Borosil Renewables, Flair Writing Industries, Jubilant Industries, Natco Pharma, and NALCO.

Easy Trip Planners Ltd. is an online travel company. It provides air-tickets, rail tickets, hotel bookings, bus booking and holiday packages, and white label services. It operates through the following segment: Air Passage, Hotel Packages, and Other Services. The company was founded by Prashant Pitti, Nishant Pitti and Rikant Pittie in 2008 and is headquartered in New Delhi, India.

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	0.00%
50-Day Moving Average	8.45
Beta	0.01
Avg. Volume	10.33M
PE Ratio	37.37

52-Week High	19.00
52-Week Low	7.82
Market Capitalization	29.2B
EPS (Annual)	0.3029
Price to Book	3.95
Revenue Per Employee	3.44M
Enterprise Value/EBITDA	N/A

EASEMYTRIP.NSE
Easy Trip Planners Limited

Feed

News

Sentiment

Fundamentals

Info

Latest EASEMYTRIP.NSE News

EASEMYTRIP.NSEEasy Trip Planners Limited